(Q40038248)

16 September 2017

0 references

Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis (English)

1 reference

16 September 2017

0 references

1 reference

Bahi Takkouche

1

1 reference

16 September 2017

Carlos Regueira-Méndez

series ordinal

2

1 reference

16 September 2017

Mahyar Etminan

series ordinal

3

1 reference

16 September 2017

language of work or name

English

0 references

publication date

7 October 2008

1 reference

Journal of the National Cancer Institute

16 September 2017

published in

1 reference

16 September 2017

volume

100

1 reference

16 September 2017

issue

20

1 reference

16 September 2017

page(s)

1439-1447

1 reference

NSAIDs and breast cancer: a possible prevention and treatment strategy

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Aspirin and cancer risk: an updated quantitative review to 2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Breast cancer and NSAID use: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

HEpiMA: software for the identification of heterogeneity in meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

NSAID use and breast cancer risk in the VITAL cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Nonsteroidal Anti-inflammatory Drugs and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Nonsteroidal antiinflammatory drugs and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Association of regular aspirin use and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Medication use and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

IL6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Aspirin use and chronic diseases: a cohort study of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Prospective study of regular aspirin use and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Cancer risk in persons receiving prescriptions for paracetamol: a Danish cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Risk of breast cancer among users of aspirin and other anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

Interaction between aspirin and ACE Inhibitors: resolving discrepancies using a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN324

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJN324

1 reference

16 September 2017

1 reference